Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
B
Barrick Mining
B
|
+$169M |
| 2 |
AMRZ
Amrize Ltd
AMRZ
|
+$69.6M |
| 3 |
NBIS
Nebius Group N.V.
NBIS
|
+$60M |
| 4 |
Q
Qnity Electronics Inc
Q
|
+$48.7M |
| 5 |
CRWV
CoreWeave
CRWV
|
+$47.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$697M |
| 2 |
Apple
AAPL
|
+$641M |
| 3 |
Microsoft
MSFT
|
+$503M |
| 4 |
Amazon
AMZN
|
+$284M |
| 5 |
Tesla
TSLA
|
+$271M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.64% |
| 2 | Consumer Discretionary | 11.52% |
| 3 | Communication Services | 11.09% |
| 4 | Healthcare | 10.44% |
| 5 | Industrials | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Kinetik
KNTK
$4.16B
| $3.28M | ﹤0.01% |
90,900
+2,300
| +3% | +$83.1K |
|
1602
Mineralys Therapeutics
MLYS
$2.31B
| $3.27M | ﹤0.01% |
90,100
+1,600
| +2% | +$64.2K |
|
|
SEM
1603
DELISTED
Select Medical
SEM
| $3.27M | ﹤0.01% |
220,100
-4,200
| -2% | -$59.4K |
|
1604
Sylvamo
SLVM
$1.55B
| $3.26M | ﹤0.01% |
67,700
+600
| +0.9% | +$27.3K |
|
1605
MannKind Corp
MNKD
$1.2B
| $3.26M | ﹤0.01% |
574,700
+14,800
| +3% | +$81.5K |
|
1606
Huntsman Corp
HUN
$1.81B
| $3.25M | ﹤0.01% |
325,474
+5,500
| +2% | +$50.4K |
|
1607
Federal Agricultural Mortgage
AGM
$2.51B
| $3.24M | ﹤0.01% |
18,481
+300
| +2% | +$50.5K |
|
|
HTO
1608
H2O America
HTO
$2.65B
| $3.24M | ﹤0.01% |
66,200
+3,200
| +5% | +$153K |
|
1609
Buckle
BKE
$2.31B
| $3.24M | ﹤0.01% |
60,600
+1,100
| +2% | +$61.3K |
|
1610
Interparfums
IPAR
$3.7B
| $3.22M | ﹤0.01% |
38,000
+700
| +2% | +$61.6K |
|
1611
Boston Beer
SAM
$1.9B
| $3.22M | ﹤0.01% |
16,500
-200
| -1% | -$41.2K |
|
1612
Interface
TILE
$2.24B
| $3.21M | ﹤0.01% |
115,100
+1,500
| +1% | +$40.9K |
|
1613
Celldex Therapeutics
CLDX
$3.35B
| $3.2M | ﹤0.01% |
117,900
+2,100
| +2% | +$55.3K |
|
1614
Innodata
INOD
$2.03B
| $3.2M | ﹤0.01% |
62,800
+1,200
| +2% | +$78.3K |
|
1615
UFP Technologies
UFPT
$2.48B
| $3.2M | ﹤0.01% |
14,400
+200
| +1% | +$42.9K |
|
1616
Pathward Financial
CASH
$1.79B
| $3.19M | ﹤0.01% |
45,000
-1,300
| -3% | -$93.2K |
|
1617
Payoneer
PAYO
$2.42B
| $3.19M | ﹤0.01% |
568,400
+5,700
| +1% | +$32.9K |
|
1618
Nicolet Bankshares
NIC
$3.73B
| $3.19M | ﹤0.01% |
26,300
| – | – |
|
1619
Harmony Biosciences
HRMY
$2.24B
| $3.18M | ﹤0.01% |
85,100
+1,600
| +2% | +$52.6K |
|
1620
WisdomTree
WT
$3.44B
| $3.18M | ﹤0.01% |
261,100
+18,800
| +8% | +$227K |
|
1621
Sunstone Hotel Investors
SHO
$2.02B
| $3.18M | ﹤0.01% |
355,749
-9,500
| -3% | -$87.1K |
|
1622
Vishay Intertechnology
VSH
$5.11B
| $3.18M | ﹤0.01% |
219,200
+3,900
| +2% | +$59.1K |
|
|
CALY
1623
Callaway Golf Company
CALY
$2.95B
| $3.17M | ﹤0.01% |
271,800
+4,700
| +2% | +$49.6K |
|
1624
Digi International
DGII
$3.23B
| $3.17M | ﹤0.01% |
73,200
+1,300
| +2% | +$52.1K |
|
1625
Spyre Therapeutics
SYRE
$8.98B
| $3.16M | ﹤0.01% |
96,500
+26,300
| +37% | +$687K |
|
Similar funds
Swiss National Bank's Q4 2025 Portfolio in Review
As of Q4 2025, Swiss National Bank held 2,386 positions worth $168B, down 2.5% from $172B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Swiss National Bank withdrew a net $7.75B in Q4 2025, closing 75 positions and reducing 690 holdings. Its most notable exit was Kellanova, an estimated $76.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Swiss National Bank opened a new position in Barrick Mining worth $197M.
- Swiss National Bank's largest Q4 2025 buy was Barrick Mining: 4,513,129 shares worth $197M.
- Swiss National Bank added most to Insmed in Q4 2025, an estimated $37.9M increase.
- Swiss National Bank's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $697M.
- Swiss National Bank fully exited Kellanova in Q4 2025, selling an estimated $76.6M.
- Swiss National Bank's ten largest holdings make up 37% of its $168B portfolio in Q4 2025.
- Swiss National Bank opened 71 new positions and closed 75 in Q4 2025.
- Swiss National Bank's portfolio value fell 2.5% quarter-over-quarter to $168B.
Based on Swiss National Bank's 13F filing for Q4 2025, filed 12 Feb 2026.